Plasmodium falciparum: DNA sequence specificity of cisplatin and cisplatin analogues

被引：5

作者：

Murray, Vincent ^{[1
]}

Campbell, Heather M. ^{[1
]}

Gero, Annette M. ^{[1
]}

机构：

[1] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia

来源：

EXPERIMENTAL PARASITOLOGY | 2011年 / 128卷 / 04期

基金：

英国医学研究理事会;

关键词：

Malaria; Transplatin; Carboplatin; Repeat sequence; DNA-targeted analogues; PLATINUM COMPLEXES; MALARIA; CIS-DIAMMINEDICHLOROPLATINUM(II); AGENTS; CARBOPLATIN; COMBINATION; DERIVATIVES; SELECTIVITY; POLYMERASE; RESISTANCE;

D O I：

10.1016/j.exppara.2011.05.002

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

In this paper, we provided evidence that cisplatin is able to form adducts with cellular DNA in Plasmodium falciparum. The DNA sequence specificity of cisplatin adduct formation was determined in trophozoite-enriched P. falciparum cells and this paper represents the first occasion that the sequence specificity of cisplatin DNA damage has been observed in malaria cells. Utilising a sub-telomeric, 692 bp repeat sequence in the P. falciparum genome, we were able to investigate the DNA adducts formed by cisplatin and five analogues. A run of eight consecutive guanines was the most prominent site of DNA damage in the malarial cells. This study suggests that the mechanism of P. falciparum cell death caused by cisplatin involves damage to DNA and hence inhibition of DNA replication and cell division. (C) 2011 Elsevier Inc. All rights reserved.

引用

页码：396 / 400

页数：5

共 50 条

[11] Intrinsically fluorescent cytotoxic cisplatin analogues as DNA marker molecules
Criado, JJ
Fernández, ER
Manzano, JL
Alonso, A
Barrena, S
Medarde, M
Pelaez, R
Tabernero, MD
Orfao, A
BIOCONJUGATE CHEMISTRY, 2005, 16 (02) : 275 - 282
[12] Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues
Kasparkova, J
Novakova, O
Najajreh, Y
Gibson, D
Perez, JM
Brabec, V
CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (11) : 1424 - 1432
[13] The Sequence Specificity of the Anti-tumour Drug, Cisplatin, in Telomeric DNA Sequences Compared with Consecutive Guanine DNA Sequences
Murray, Vincent
Kandasamy, Niruba
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (03) : 177 - 181
[14] Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Neumann, Wilma
Crews, Brenda C.
Sarosi, Menyhart B.
Daniel, Cristina M.
Ghebreselasie, Kebreab
Scholz, Matthias S.
Marnett, Lawrence J.
Hey-Hawkins, Evamarie
CHEMMEDCHEM, 2015, 10 (01) : 183 - 192
[15] Prospects for improved cisplatin analogues
Kelland, LR
OVARIAN CANCER 4, 1996, : 249 - 258
[16] DNA interactions of antitumor cisplatin analogues containing enantiomeric amine ligands
Delalande, O
Malina, J
Hofr, C
Nováková, O
Natile, G
Kozelka, J
Brabec, V
JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 86 (01) : 201 - 201
[17] Fluorescent Cisplatin Analogues and Cytotoxic Activity
Rodriguez-Fernandez, E.
Manzano, J. L.
Alonso, A.
Almendral, Ma. J.
Perez-Andres, M.
Orfao, A.
Criado, J. J.
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (32) : 4314 - 4327
[18] Alternative of cisplatin - Introduction of rhodium analogues
Mandal, Arup
JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2024, 101 (11)
[19] The Influence of Chromatin Structure on DNA Damage Induced by Nitrogen Mustard and Cisplatin Analogues
Galea, Anne M.
Murray, Vincent
CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (06) : 578 - 589
[20] DNA Sequence Polymorphism of the Lactate Dehydrogenase Genefrom Iranian Plasmodium vivax and Plasmodium falciparum Isolates
Feleke, Daniel Getacher
Nateghpour, Mehdi
Haghi, Afsaneh Motevalli
Hajjaran, Homa
Farivar, Leila
Mohebali, Mehdi
Raoofian, Reza
IRANIAN JOURNAL OF PARASITOLOGY, 2015, 10 (04) : 505 - 516

← 1 2 3 4 5 →